Osmotica Pharmaceuticals Plc Operating Income

Osmotica Pharmaceuticals Plc (OSMT) currently reports a operating income of $-57M as of June 2023. That compares with $-69M in the prior-year period — up 16.4% year over year. Use the charts on this page to explore Osmotica Pharmaceuticals Plc's operating income history and peer comparisons.

Osmotica Pharmaceuticals Plc's operating income increased from $-69M to $-57M — a 16.4% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Osmotica Pharmaceuticals Plc reported $-57M in operating income as of June 2023. That compares with $-69M in the prior-year period — up 16.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-57M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Osmotica Pharmaceuticals Plc, and consider following OSMT for alerts when major investors trade the stock.

Osmotica Pharmaceuticals Plc is classified in the Healthcare sector. On operating income, it currently shows $-57M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OSMT with unrelated industries.